107篇中国学术论文造假遭外国期刊撤稿
<p>4月20日，世界最大学术出版机构之一的施普林格自然出版集团发表撤稿声明，旗下期刊《肿瘤生物学》宣布撤回107篇发表于2017年至2017年的论文，原因是同行评议造假。107篇论文全部和中国研究机构有关，不仅包括复旦大学附属华山医院、中国医学科学院北京协和医院等三甲医院在列，浙江大学、武汉大学、同济大学等知名高校也不鲜见。</p><p><span word="An">An</span> <span word="international">international</span> <span word="medical">medical</span> <span word="journal">journal</span>'<span word="s">s</span> <span word="retraction">retraction</span> <span word="of">of</span> 107 <span word="research">research</span> <span word="papers">papers</span> <span word="from">from</span> <span word="China">China</span>, <span word="many">many</span> <span word="of">of</span> <span word="them">them</span> <span word="by">by</span> <span word="clinical">clinical</span> <span word="doctors">doctors</span>, <span word="has">has</span> <span word="reignited">reignited</span> <span word="concerns">concerns</span> <span word="over">over</span> <span word="academic">academic</span> <span word="credibility">credibility</span> <span word="in">in</span> <span word="the">the</span> <span word="country">country</span>.</p><p>一家国际医学杂志撤销了107篇中国学术论文，由此引发了人们对中国学术诚信的关注。被撤稿的作者多数是临床医生。</p><p><span word="Tumor">Tumor</span> <span word="Biology">Biology</span>, <span word="a">a</span> <span word="journal">journal</span> <span word="published">published</span> <span word="by">by</span> <span word="Springer">Springer</span> <span word="Nature">Nature</span>, <span word="announced">announced</span> <span word="last">last</span> <span word="week">week</span> <span word="that">that</span> <span word="it">it</span> <span word="had">had</span> <span word="retracted">retracted</span> <span word="the">the</span> <span word="papers">papers</span> <span word="after">after</span> <span word="an">an</span> <span word="investigation">investigation</span> <span word="showed">showed</span> <span word="the">the</span> <span word="peer">peer</span> <span word="review">review</span> <span word="process">process</span> <span word="had">had</span> <span word="been">been</span> <span word="compromised">compromised</span>.</p><p>由施普林格自然集团出版的杂志《肿瘤生物学》上周宣布，调查显示，这107篇论文的同行评审过程存在问题，因此已被撤稿。</p>
页:
[1]